Callan JMB Announces Participation in the DealFlow Discovery Conference on January 28-29, 2026
Callan JMB Signs Manufacturing Oversight, Federal Deployment, and Commercialization Agreement of Multi-Asset Therapeutic Pipeline with Attune for Approximately $50 to $75 Million in Total Revenue
Callan JMB Inc. (NASDAQ:CJMB) Announces Major Strategic Pivot to Cold-Chain Infrastructure for the $100 Billion GLP-1 Pharmaceutical Market; Initiates Retrofitting of Texas cGMP Facility [Yahoo! Finance]
Founder of Callan JMB Picks Up 1.3% More Stock [Yahoo! Finance]
Callan JMB Inc. GAAP EPS of -$0.61, revenue of $1.44M [Seeking Alpha]